Bill Link is a Versant Managing Director.
Bill specializes in early-stage investing in medical devices at Versant. Prior to co-founding Versant Ventures, Bill was a general partner at Brentwood Venture Capital. With more than two decades of operations experience in the healthcare industry, he has a proven record of building and managing large, successful medical product companies. His extensive knowledge of medical devices, particularly in ophthalmology, has contributed to Versant’s recognized leadership in this specialty area.
Perhaps Bill’s greatest operational success was as founder, chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products, which was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later Bill served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009.
Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine.